Coronavirus Update: Lilly Begins Clinical Trial Of Antibody Therapy
Plus News From Resverlogix, Sun And Syntekabio
• By Scrip Team
New Delhi: Trains and other aspects of life in India have resumed after more than two months of lockdown, despite COVID-19 cases continuing to surge in the country.
Keep up with the top pharma business news of the week. On the go.
